4
Changes in Ownership
Emergent BioSolutions Inc. Filed Acc 0001367644-20-000025
Director sold 15,786 shares at $58.96 ($930,714)
- Director acquired 15,786 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
SULLIVAN LOUIS W · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-03-04 | Exercise or conversion : show line 1 in the form | +7,893 | $13.00 | $102,609 | 68,359 | D |
| 2020-03-04 | Sale : show line 2 in the form | −7,893 | $58.96 | $465,357 | 60,466 | D |
| 2020-03-04 | Exercise or conversion : show line 3 in the form | +7,893 | $14.71 | $116,106 | 68,359 | D |
| 2020-03-04 | Sale : show line 4 in the form | −7,893 | $58.96 | $465,357 | 60,466 | D |
| Open-market sales · 15,786 sh · avg $58.96 · $930,714 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-03-04 | Exercise or conversion : show line 5 in the form Employee Stock Options (Right to Buy) | −7,893 | $14.71 | $116,106 | 0 | D |
| 2020-03-04 | Exercise or conversion : show line 6 in the form Employee Stock Options (Right to Buy) | −7,893 | $13.00 | $102,609 | 0 | D |
Loading xslF345X03/wf-form4_158353064805074.xml…